Founded
1 Dec 2006
Website
VCID: 366455
Profile
Corporate information
Registration country
Registration country
Investment activity status
Active investor
Company type
Discoverer and developer of novel small molecule drugs for the treatment of inflammatory and autoimmune disorders and organ transplant rejection.Funding
Funding rounds
Cap Table
Current and past shareholders
| Investor | Contacts | Round | |
|---|---|---|---|
|
Sanderling Ventures |
+1 (650) 401-2000 |
N/A |